External Counter Plusation (ECP) is marketed in the SAARC region by RMD MEDIAIDS LTD. The company was incorporated on November 1997 in Delhi.
The lead Directors are Mr. R R Sharma M. Sc. (Hons), MBA - Director Marketing and Dr. Mamta Sharma Ph. D. (Biotech) - Director Technical Services.
The Cardiology Division markets External Counter Pulsation Device (ECP) - a unique non-invasive treatment device for CAD/CHF/Angina. External Counter Plusation (ECP) is a FDA approved device with over 500 installations in USA and close to 40 in India for over 5 years now of which we have a sizable member share of over 25% (11 installations) in 3 year period since we started marketing this system in Oct. 2003.
The company has factory trained engineers to be able to deliver prompt after sales service. We boast of being able to give close to 100% uptime on our installations, all over the SAARC region.